4,514
Participants
Start Date
December 27, 2024
Primary Completion Date
July 31, 2025
Study Completion Date
August 31, 2025
nasal antimicrobial photodisinfection therapy
Application of NF-031 solution (methylene blue 0.01% USP (methylthioninium chloride) and 0.25% chlorhexidine gluconate) in the nares followed by 2-minutes of light with nasal illuminators. The application is repeated a second time for total treatment time of 5-minutes.
NOT_YET_RECRUITING
Johnston Willis Hospital, Richmond
RECRUITING
HCA Brandon Florida, Brandon
RECRUITING
HCA Florida NorthSide Hospital, St. Petersburg
RECRUITING
HCA Florida Largo Hospital, Largo
RECRUITING
HCA Florida Trinity Hospital, Trinity
RECRUITING
Centennial Medical Center, Nashville
RECRUITING
Medical City Frisco Hospital, Frisco
RECRUITING
Medical City Plano, Plano
RECRUITING
Medical City Dallas, Dallas
RECRUITING
Medical City Heart and Spine Hospital, Dallas
RECRUITING
HCA Houston Healthcare Kingwood, Kingwood
RECRUITING
HCA Houston Healthcare Clear Lake Hospital, Webster
NOT_YET_RECRUITING
Methodist Metropolitan Hospital, San Antonio
RECRUITING
Methodist Main Hospital, San Antonio
RECRUITING
Methodist Stone Oak, San Antonio
RECRUITING
Swedish Medical Center, Englewood
Lead Sponsor
Ondine Biomedical Inc.
INDUSTRY